Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
6.95
0.80%
After-hours: Aug 15, 2025, 03:59 PM EDT

Passage Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-64.77M -102.06M -136.13M -185.39M
Depreciation & Amortization
3.08M 3.72M 3.68M 1.54M
Stock-Based Compensation
5.82M 10.92M 18.95M 32.69M
Other Working Capital
4.76M 8.13M -3.08M 9.22M
Other Non-Cash Items
3.71M 3.82M 3.77M 10.07M
Deferred Income Tax
n/a n/a n/a 2.78M
Change in Working Capital
4.2M 5.34M -8.49M 11.42M
Operating Cash Flow
-47.96M -78.26M -118.21M -126.88M
Capital Expenditures
-34K -146K -5.27M -25.64M
Cash Acquisitions
n/a n/a 3M 8M
Purchase of Investments
-88.17M -129.43M -157.84M -202.55M
Sales Maturities Of Investments
143.15M 194.81M 188.31M 182.37M
Other Investing Acitivies
n/a n/a -3M -8M
Investing Cash Flow
54.95M 65.24M 25.2M -45.81M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
132K n/a -1.79M -37K
Financial Cash Flow
8.87M 135K -1.35M 166.66M
Net Cash Flow
15.86M -12.89M -94.36M -6.04M
Free Cash Flow
-47.99M -78.41M -123.48M -152.52M